评估胰岛素耐药性和亚临床甲状腺功能低下症之间的关联,使用甘油三指数-葡萄糖指数:一个横截面研究
Rinky Thakur1, Samir Kumar2, Rajeev Kumar Neeraj3
1Senior Resident, Department of Pharmacology, IGIMS, Patna, India.
Maedica
|August 27, 2024
概括
亚临床甲状腺功能低下症 (SCH) 与胰岛素耐药性增加有关,这是由甘油三-葡萄糖 (TyG) 指数表明的. 这种简单的指数可以帮助早期发现和管理糖尿病等相关疾病.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 甲状腺疾病和糖尿病经常同时存在,这表明甲状腺功能和胰岛素抵抗之间存在联系.
- 甘油三糖 (TyG) 指数是抗胰岛素的具有成本效益的标志物,但其与亚临床甲状腺功能低下症 (SCH) 的关联尚未研究.
研究的目的:
- 用TyG指数评估SCH和胰岛素抵抗之间的关系.
- 为了比较SCH患者的TyG指数值与euthyroid对照.
- 调查TyG指数和甲状腺特征参数 (TSH,FT3,FT4) 之间的相关性.
主要方法:
- 一项涉及35名SCH患者的病例控制研究和35名匹配的安甲状腺对照.
- 两个组之间的TyG指数的计算和比较.
- 评估TyG指数和甲状腺功能测试之间的相关性.
主要成果:
- 与对照组相比,SCH患者的TSH水平显著更高.
- 在SCH和对照组之间没有观察到FT3或FT4水平的显著差异.
- 在SCH组中,TyG指数显著升高,表明胰岛素耐药性较高,但与甲状腺参数没有显著的相关性.
结论:
- 亚临床甲状腺功能低下症与胰岛素抵抗有关,通过TyG指数来衡量.
- TyG指数可以作为一种有价值的工具,用于早期查SCH.患者的胰岛素耐药性.
- 早期识别可以促进糖尿病和心血管疾病等相关疾病的管理.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Hypoglycemia and Glucagon
218
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
218
Synthesis and Regulation of Thyroid Hormones
4.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.3K
Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520


